Laboratory Manager
Laboratory Manager: Thinzar Myint (BS, MS)…
Laboratory Manager: Thinzar Myint (BS, MS)…
University of Florida researchers will use a new $5 million grant to develop a “pancreatic islet on a chip” — a platform that will allow them to more efficiently and effectively study Type 1 diabetes and potential treatments for the condition.
Human Atlas of Neonatal Development and Early Life-Immunity (HANDEL-I) The early life events that influence immune system development have implications in the development of a multitude of diseases including type 1 diabetes (T1D). The immune system is actively evolving and integrating dynamic signals from the host’s environment, not…
University of Florida and Kings College London have secured a $3.7 million grant funded by Adaptive Biotechnologies and the Leona M. and Harry B. Helmsley Charitable Trust to profile T cell receptor sequences in Type 1 Diabetes. Congratulations to co-investigators Dr. Todd Brusko and Dr. Mark Peakman!…
The Brusko Lab is currently recruiting a Postdoc to work on our NIH R01 “The CD226 and TIGIT Costimulatory Axis in Type 1 Diabetes.”…
The 1-year C-peptide was significantly higher (β-cell preservation) in subjects treated with ATG versus placebo (P = 0.0003) but not in those treated with ATG/GCSF versus placebo (P = 0.031).
The Brusko Lab and collaborators are trying to better understand how genes influence T1D risk…
Dr. Wen-I Yeh recently published her work on the phenotype of Treg expressing autoreactive TCR.
Dr. Laura Jacobsen, MD, recently teamed with the Brusko Lab on her review of TCR profiling in T1D.
Autoimmune diseases are called “invisible diseases” as symptoms are not seen. AI is Not Invisible is trying to help bring awareness for the 80 autoimmune diseases that can affect us.